These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 16377538)

  • 1. Use of intravenous immunoglobulin G (IVIG).
    Looney RJ; Huggins J
    Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies].
    Lewandowicz-Uszyńska A; Jankowski A
    Pol Merkur Lekarski; 2011 Jun; 30(180):409-12. PubMed ID: 21751549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin therapy: indications, potential side effects, and treatment guidelines.
    Suez D
    J Intraven Nurs; 1995; 18(4):178-90. PubMed ID: 7629638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
    Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
    Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin: a review.
    Eibl MM; Wedgwood RJ
    Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of high dose intravenous immunoglobulin in neurologic disease].
    Korsak J; Zaleska B; Orłowska E; Kotowicz J
    Pol Merkur Lekarski; 2005 Jul; 19(109):98-101. PubMed ID: 16194039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of intravenous immunoglobulin (IVIG) therapy.
    Katz U; Achiron A; Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral sinus thrombosis in a patient with humoral immunodeficiency on intravenous immunoglobulin therapy: a case report.
    Barada W; Muwakkit S; Hourani R; Bitar M; Mikati M
    Neuropediatrics; 2008 Apr; 39(2):131-3. PubMed ID: 18671192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance.
    Radosevich M; Burnouf T
    Vox Sang; 2010 Jan; 98(1):12-28. PubMed ID: 19660029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoglobulins--merely expensive or also useful?].
    Paar WD
    Ther Umsch; 1995 Oct; 52(10):639-44. PubMed ID: 7482374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections.
    Ferrara G; Zumla A; Maeurer M
    Am J Med; 2012 Oct; 125(10):1036.e1-8. PubMed ID: 22608788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subcutaneous immunoglobulin substitution and therapy].
    Gulácsy V; Maródi L
    Orv Hetil; 2011 Jan; 152(2):64-7. PubMed ID: 21177233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilisation of intravenous immunoglobulin in New Zealand: a clinical audit.
    Hutchinson D; Flanagan P; Charlewood R; Mitchell T
    N Z Med J; 2006 Dec; 119(1246):U2340. PubMed ID: 17151714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
    Pac M
    Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of interleukin-6 and interleukin-10 in patients with multiple sclerosis during intravenous immunoglobulin infusion].
    Kazibutowska Z; Motta E; Huć M; Strzała-Orzeł M; Woźnik G
    Wiad Lek; 2006; 59(9-10):626-9. PubMed ID: 17338118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of immunoglobulins activity].
    Kowalczyk D
    Pol Merkur Lekarski; 2011 Jun; 30(180):397-9. PubMed ID: 21751546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.